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Integrins mediate a neuronal survival signal for oligodendrocytes
Emma E. Frost*†, Philip C. Buttery*‡, Richard Milner* 
and Charles ffrench-Constant*§
Target-dependent survival of newly differentiated cells is
an important part of neural development. In the case of
myelin-forming oligodendrocytes, it matches the number
of oligodendrocytes to the available axons [1]. In addition
to growth factors, an axonal signal regulates this survival:
when axons are transected, oligodendrocytes die and,
conversely, when the number of axons is increased by
genetic manipulation, oligodendrocyte numbers increase
[2,3]. Newly formed oligodendrocytes that fail to contact
axons undergo apoptosis, and co-culture experiments that
model axon–glial interactions in vitro reveal a neuronal
survival effect not present in neuron-conditioned
medium [4,5], suggesting that the signal is non-diffusible
and present on the surface of axons. The nature of these
neuronal signals is unknown, as are the mechanisms by
which they interact with growth-factor-mediated survival
signals. As integrins can regulate survival in other cell
types [6–8], we determined whether integrins are involved
in the neuronal survival effect. We found that the laminin
receptor α6β1 integrin, which is expressed on
oligodendrocytes, enhances the sensitivity of
oligodendrocytes to the survival effect of growth factors.
On the basis of this interaction between integrin and
growth-factor-mediated signalling, we propose a simple
model by which signals from axons and other cell types
might interact to regulate oligodendrocyte cell numbers.
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Results and discussion
To examine the role of integrins in neuron-derived
oligodendrocyte survival signals, we used a xenoculture
system in which mouse oligodendrocyte precursor cells
are added to an established culture of rat dorsal root
ganglia (DRG). We have shown previously that, in these
cultures, oligodendrocyte precursor cells associate with
DRG neurites and differentiate into oligodendrocytes [9].
The presence of normal axon–glial interactions is con-
firmed by changes in oligodendrocyte morphology: cell
processes run parallel to the neurites and, occasionally,
myelin sheaths can seen by electron microscopy [9]. Cell
death in oligodendrocytes, which were defined by
expression of the cell-surface marker galactocerebroside
(GalC) [10], was visualised by staining unfixed cultures
with propidium iodide to detect nuclear labelling in
those cells that have died and thus fail to exclude the
dye. As reported previously, the majority of GalC+ cells
showed labelled nuclei with a condensed morphology
consistent with apoptosis by day 6 when cultured in the
absence of DRG whereas few such cells were seen in the
presence of DRG (Figure 1). These results are consistent
with work using rat–rat co-cultures, in which it has also
been shown that conditioned medium from DRG does
not exert a survival effect [5], thus validating our xeno-
culture approach for examining axonal survival signals.
Oligodendroglial cells express two classes of integrins:
α6β1 and a number of different αv integrins [11,12]. To
block the function of these integrins and so examine their
role in oligodendrocyte survival within xenocultures, we
used two rat monoclonal antibodies G0H3 and C8F12.
G0H3 is a well-characterised blocking antibody against
α6β1 integrin [13]. C8F12 (a kind gift from C. Streuli)
recognises all αv integrins on glial cells [12] and inhibits
adhesion of these cells to vitronectin substrates (R.M.,
unpublished observations), showing that it also functions
as a blocking antibody at the concentration used in this
study. Both antibodies recognise mouse but not rat inte-
grins and therefore block oligodendrocyte (mouse) inte-
grins but not the DRG (rat) integrins in the xenocultures.
G0H3 had no effect after 3 days but significantly inhibited
the survival-promoting effect of the co-culture by 6 days,
with the number of GalC+ cells excluding propidium
iodide falling from 82 ± 4% to 36 ± 3% (n = 3, p < 0.05).
The level of survival seen in the co-cultures after 6 days in
the presence of G0H3 was similar to that seen in oligoden-
drocytes grown without neurons (Figure 1). C8F12, in
contrast, had no effect on the survival of oligodendrocytes
in co-culture at 6 days (Figure 1).
These results show that α6β1 integrin, but not αv inte-
grins, regulates oligodendrocyte survival in co-culture and
is therefore involved in a neuronal survival response. The
α6β1 integrin is a receptor for the laminin family of extra-
cellular matrix molecules, raising the possibility that
laminins can promote oligodendrocyte survival directly.
To examine this, we switched to the use of rat oligoden-
drocyte precursors in purified cultures, as the survival
characteristics of these cells have been well established in
isolated cultures [14] and their integrin expression profile
is similar to that of the mouse cells [11].
To generate newly formed oligodendrocytes, oligodendro-
cyte precursors were expanded in medium containing
fibroblast growth factor-2 (FGF-2, 10 ng/ml), which acts
both as a mitogen and a block to final differentiation [15],
and then transferred to medium lacking the growth factor
in which they undergo constitutive differentiation by a
cell-intrinsic mechanism [16]. Cells were then plated onto
different extracellular matrix substrates that provide
ligands for αv integrins (vitronectin, fibronectin) and α6β1
integrin (laminin-2), and the number of living cells was
determined by MTT labelling (see Supplementary mater-
ial for method; [14]). Laminin-2 (merosin) was chosen in
preference to laminin-1, as laminin-2 is expressed in the
mammalian central nervous system [17–19] and humans
lacking laminin-2 show abnormalities of myelina-
tion [20,21]. When added to poly-D-lysine-coated wells,
these substrates enhanced survival very little. The number
of cells alive after 4 days (expressed as a percentage of those
present at 12 hours after plating) was 47.8 ± 1.5%
(mean ± standard deviation) on a control bovine serum
albumin (BSA) substrate and 46.7 ± 2.7, 53.9 ± 1, 60.5 ± 5.3
and 66.8 ± 4.7% on substrates of fibronectin, vitronectin,
laminin-2 (all at 50 µg/ml, n = 3) and a vitronectin–laminin-2
mixture (both at 25 µg/ml, n = 3), respectively. In contrast
platelet-derived growth factor (PDGF), which is known to
act as a survival factor for newly formed oligodendrocytes
[14], increased the number of surviving cells at 4 days to
144.6 ± 30.5% (n = 3). 
Although α6β1-integrin-mediated signalling was sufficient
to promote survival in only very few cells, this integrin was
necessary for survival in the majority of oligodendrocytes.
In parallel experiments, integrin blockers were added to
cultures of newly formed oligodendrocytes in the presence
of the mixed vitronectin–laminin-2 substrate, designed to
provide ligands for all of the integrins expressed on the
cells. As shown in Figure 2, a polyclonal antiserum against
β1 integrin resulted in only 30% of the cells surviving until
4 days. The terminal-deoxynucleotidyl-mediated dUTP
nick end labelling (TUNEL) assay showed many positive
cells in the presence of the antiserum, confirming that this
reduction in numbers reflected DNA cleavage as seen in
programmed cell death. A control purified rabbit antiserum
had no effect on survival whereas, as expected, all cells
died in the presence of staurosporin, a kinase inhibitor
known to induce apoptosis in oligodendrocytes [14]. The
lack of a blocking antibody specific for rat α6β1 integrin
precludes a direct demonstration of the role of this integrin
in survival in rat cells. There is, however, strong indirect
evidence for such a role. First, α6β1 integrin is the only β1
integrin expressed on these cells [11]. Second, linear or
cyclic RGD peptides (which block all αv integrins) and the
monoclonal antibodies F11 and P1F6 (which block αvβ3
and αvβ5 integrins, respectively) did not cause any cell
death in this assay (Figure 2).
The demonstration that α6β1 integrin is necessary but not
sufficient for oligodendrocyte survival raises the possibility
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Figure 1
Oligodendrocyte survival in xenocultures
requires α6β1 integrin. Rat DRG–mouse
oligodendrocyte xenocultures were
established using a modification of our
previously described protocol [9] (see the
Supplementary material). The monoclonal
antibodies G0H3 and C8F12 (both at
20 µg/ml) were added at the same time as the
oligodendrocyte precursors to the established
DRG cultures. Exclusion of propidium iodide
(PI, used at 20 µg/ml) was assessed at 3 or
6 days, after which the cultures were fixed and
stained by immunofluorescence using an 
anti-GalC monoclonal antibody. Only GalC+/PI+
cells were counted to assess survival in newly
formed oligodendrocytes, although many
PI+/GalC– cells were also seen. Note that the
survival effect of DRGs was significantly
reduced by G0H3 but not by C8F12.
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that signalling from this integrin interacts with signalling
downstream of survival-promoting growth factor recep-
tors such as PDGF. To examine this, we repeated the
survival assays on laminin-2 and fibronectin in the pres-
ence of different concentrations of PDGF. In the
absence of PDGF, there was very little effect of extracel-
lular matrix (Figure 3). In the presence of PDGF,
however, laminin-2 but not fibronectin significantly
enhanced the number of cells present at 4 days (n = 3,
p < 0.05 for both 1 ng/ml and 10 ng/ml PDGF as com-
pared with survival on poly-D-lysine). Examination of the
nuclear morphology of GalC+ oligodendrocytes in these
cultures confirmed that this reflected an increase in sur-
vival of newly formed oligodendrocytes in addition to
any effect of PDGF on proliferation and survival of oligo-
dendrocyte precursors. The number of oligodendrocytes
with normal nuclear morphology and not showing evi-
dence of apoptosis (assessed by propidium iodide stain-
ing after fixation) was 70.3 ± 7.3% on laminin-2 as
compared with 28 ± 11.2% on poly-D-lysine (n = 3,
p < 0.01) and 38.3% ± 8.3 on fibronectin (n = 3, p < 0.01
as compared with laminin-2), confirming that α6 and not
αv integrins play the major role in the oligodendrocyte
survival response.
We can draw two conclusions from our results. First, a
neuron-derived survival signal for oligodendrocytes, as
modelled in xenoculture, requires the α6β1 integrin.
Second, the survival effect of this integrin is mediated
through interactions with growth-factor-driven signalling
pathways. The finding that αv integrins appear to play
little, if any, role in survival of oligodendroglial cells is
surprising, given that αvβ3 has been shown to play a role
in the survival of melanoma and endothelial cells [22,23].
Nevertheless, our demonstration that α6β1 integrin is
required for oligodendroglial survival complements two
previous studies showing roles for this integrin in neural
cell survival. Zhang and Galileo [24] showed that infec-
tion of neuroepithelial cells with a retrovirus expressing
an antisense α6 integrin construct reduces the survival of
neuronal precursor cells following their migration into
the developing cortex. Chen and Strickland [25] have
also demonstrated that this integrin is important for the
survival of adult hippocampal neurons in vivo. Taken
together, these results raise the possibility that α6β1
integrin plays an important role in the central nervous
system as an essential part of the survival signalling
pathway in neuronal and glial cells.
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Figure 2
Oligodendrocyte survival is inhibited by blocking β1 integrin. Newly
formed rat oligodendrocytes were generated by expanding
oligodendrocyte precursors ([11] and see Supplementary material) in
Sato-supplemented DMEM (see Supplementary material) containing
FGF-2 (10 ng/ml) and 10% FCS, and then replating the cells at
5000 cells per well on laminin-2–vitronectin substrates (25 µg/ml
each; see Supplementary material) in 0.5% FCS/Sato media. Live cells
were counted at 12 h and at 4 days using the MTT assay as described
previously [14]. Survival is expressed as a percentage of the cells
present at 12 h in the presence of the following integrin inhibitors
added at the time of replating: RGD and RGE peptides, 100 µg/ml
each; cyclic RGD (cRGD) and cRAD peptides, 50 µg/ml each; anti-β1
integrin antiserum (a kind gift of C. Streuli) and control rabbit
immunoglobulin G (IgG), 250 µg/ml; staurosporin, 2 mM;
dimethylsulfoxide (DMSO), 0.2%; monoclonal F11 and P1F6 blocking
antibodies against αvβ3 and αvβ5 integrins, respectively, 20 µg/ml.
The antibody against β1 integrin, and not the αv integrin inhibitors,
blocked survival of the rat cells in isolated culture.
0
20
40
60
80
100
120
Current Biology   
P
er
ce
nt
ag
e 
ol
ig
od
en
dr
oc
yt
e
su
rv
iv
al
 o
n 
da
y 
4 
RG
E
RG
D
cR
AD
cR
G
D
Ra
bb
it I
gG
An
ti-β1
 in
teg
rin
St
au
ro
sp
or
in
DM
SO F1
1
P1
F6
Figure 3
Oligodendrocyte survival mediated by the interaction between
growth factors and integrins. Cells were prepared as described in
Figure 2 and replated onto poly-D-lysine (PDL, 10 µg/ml), fibronectin
or laminin-2 (both 25 µg/ml) in the presence of the indicated PDGF
concentrations. Survival was determined at day 4 using the MTT
assay, and expressed as a percentage of survival seen in 10 ng/ml
PDGF on PDL. Laminin-2, but not fibronectin, enhanced the PDGF
survival response.
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Our conclusions suggest a simple model to explain one
of the axonal survival signals for developing oligodendro-
cytes that play such a critical role in normal myelination.
Laminin-2 is expressed by at least one class of neuron
whose axons are myelinated, the cerebellar Purkinje
cells [19]. The presence of laminin-2 on the axonal
surface would enhance the sensitivity of contacting oligo-
dendrocytes to PDGF derived from white-matter astro-
cytes and other cells within the myelinated tracts. The
effect of this increased sensitivity to PDGF mediated by
integrin signalling will therefore be to provide an
enhanced survival signal to those oligodendrocytes that
contact a sufficient number of axons. The concentrations
of PDGF in white matter tracts are known to be limiting
for survival in vivo, as shown by the increased number of
oligodendrocytes observed in the optic nerves of animals
transplanted with PDGF-secreting cell lines [14]. This
enhanced signal will therefore increase the chance of
oligodendrocyte survival in the competition for the
limited quantities of PDGF and so provide a mechanism
for the selection only of those oligodendrocytes that estab-
lish axonal contact. Our experiments therefore provide the
first evidence as to both the identity of an axonal survival
signal and a mechanism by which the receptor for this
signal interacts with previously described growth factor
signalling within the oligodendrocyte to regulate the final
number of oligodendrocytes in the central nervous system. 
Supplementary material
Supplementary material including additional methodological detail is
available at http://current-biology.com/supmat/supmatin.htm.
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Supplementary materials and methods
Preparation of oligodendrocyte precursor cells
Purified oligodendrocyte precursors were obtained from neonatal fore-
brains by the method of McCarthy and de Vellis [S1] with modifications.
Briefly, forebrains from post-natal day 0–2 Sprague-Dawley rat pups
were dissected free of meninges and minced with fine scissors. They
were then incubated for 1 h in a solution of 30 U/ml papain (Worthing-
ton), 0.24 mg/ml cysteine (Sigma) and 40 µg/ml DNAase I type IV
(Sigma) in 1 ml MEM (as described in [S2]). Supernatant was then
removed and 1 ml ovomucoid trypsin inhibitor (OTI) solution (530 µg/ml
BSA fraction V (Sigma), 1.14 mg/ml trypsin inhibitor (Boehringer
Mannheim), 40 µg/ml DNase (Sigma) in L-15 media (Sigma)) added.
After 2–3 min, the supernatant was removed and replaced with fresh
OTI, in which the cells were dissociated by trituration through a Gilson
1 ml Pipetman, followed by a syringe and 21-gauge needle. Cells were
then diluted in DMEM supplemented with 4 mM L-glutamine and either
10% foetal calf serum (FCS, for the rat cells) or 10% horse serum
(HS, for mouse cells), centrifuged and resuspended in supplemented
DMEM solution before being plated out in Falcon flasks pre-coated
with PDL (5 µg/ml). Media was exchanged every 3 days. After
10–20 days of culture, the flasks were placed on a rotatory shaker
(New Brunswick Orbital) at 250 rpm for 2 h to remove any loosely
adherent microglia. A subsequent prolonged shake for 20–24 h dis-
lodged large numbers of oligodendrocyte precursors from the underly-
ing monolayer (consisting predominantly of astrocytes and fibroblasts)
into the supernatant. The supernatant was retrieved and contaminat-
ing microglia were removed by their differential adherence, during a
30 min incubation, to non-tissue culture plastic petri dishes (Media).
The cell suspension was then centrifuged at 1000 rpm for 5 min and
resuspended in either DMEM/10% FCS containing FGF-2 (Peprotech,
recombinant human, 10 ng/ml) for the expansion of rat precursors prior
to their use in the survival assays, or in Sato medium supplemented with
1% HS and 5 ng/ml nerve growth factor (NGF) for the mouse cells
before their addition to the dorsal root ganglion (DRG) cultures. Sato
solution was DMEM supplemented with bovine insulin (Sigma, 5 µg/ml),
human transferrin (Sigma, 50 µg/ml), BSA fraction V (Sigma, 100 µg/ml),
progesterone (Sigma, 6.2 ng/ml), putrescine (Sigma, 16 µg/ml), sodium
selenite (Sigma, 5 ng/ml), T3 (Sigma, 400 ng/ml), T4 (Sigma, 400 ng/ml),
L-glutamine (Sigma, 4 mM), penicillin and streptomycin (Sigma).
DRG cultures
DRGs were dissected from embryonic day 15.5 rats and incubated in
retinal buffer (RB) with 30 U/ml Papain at 37°C for 20–25 min. RB is
200 ml HBSS without calcium, magnesium, phenol red or bicarbonate,
but containing 400 mg BSA (Sigma), 40 mg cysteine (Sigma), 239 mg
HEPES (Sigma), 578 g D-Glucose (Sigma), 38 mg CaCl2 (Sigma),
14 mg MgSO4 (Sigma), 20 mg MgCl2 (Sigma), 16 mg NaHCO3
(Sigma)  RB was then removed and replaced with trypsin inhibitor and
DNase in 20 ml HBSS containing 60 mg BSA, 10,000 U DNase
(Sigma), 5 mg trypsin inhibitor (Sigma) and 0.2 ml MgSO4 (3.8% stock),
within which the cells were triturated to a single cell suspension. These
cells were then plated onto 6-well plates (Nunc) coated with 5 µg/ml
poly-D-lysine followed by 0.01% calf skin type-1 collagen (Sigma) and
10 µg/ml EHS laminin (Sigma). Cells were grown in a medium consist-
ing of 50% DMEM/50% F12 containing Sato supplementation as above
and also containing 1% FCS, 0.01 mM 5′fluoro-2-deoxyuridine (5FU)
and 0.01 mM uridine (both from Sigma) and 20 ng/ml NGF. To enhance
the removal of contaminating cells, cells were switched to media lacking
serum for 24 h after 2 days. Once a stable neurite network was estab-
lished, cells were switched to DMEM/F12 Sato with 0.5% FCS, 5 ng/ml
NGF, 5FU and uridine. Mouse oligodendrocyte precursors prepared as
above were then added and the cultures maintained in DMEM/F12 Sato
supplemented with 1% HS and 5 ng/ml NGF and lacking mitotic
inhibitors for up to 6 days. 
Preparation of substrates for survival assays.
Wells were precoated with poly-D-lysine (Sigma) at 10 µg/ml
overnight, before being washed once with distilled water. Fibronectin
(bovine, Sigma), merosin (human placental, Gibco BRL–Life Tech-
nologies) and vitronectin (bovine, Sigma) were diluted to 50 µg/ml in
PBS before coating for survival experiments, and coated either at that
concentration, or as 50:50 mixtures with one another in the case of
fibronectin/merosin and vitronectin/merosin mixed substrates. Sub-
strates were coated for 4 h at 37°C. These were then blocked for at
least 30 min with 0.3% heat-inactivated BSA (fraction V, Sigma) before
being washed once with PBS and plated with cells. BSA was heat-
inactivated by incubation in a water bath at 80°C for 30 min.
Antibodies and blocking peptides
Anti-β1 integrin polyclonal antibody was a kind gift from C. Streuli (Man-
chester University); it was raised in rabbit against mouse α4β1 integrin
subunit followed by affinity purification. Affinity purified F11 (anti-β3 inte-
grin) mouse monoclonal antibody was a generous gift from Michael
Horton (University College London). Affinity purified P1F6 (anti-αvβ5
receptor) mouse monoclonal blocking antibody was from Chemicon.
GRGDSP and GRGESP hexapeptides (RGD/E peptides) were from
Life Technologies. Cyclic RGD (cRGD) peptide and cRAD control were
generous gifts from Simon Goodman (Merck).
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